These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7634432)

  • 1. The synergism between bovine papillomavirus type 4 and quercetin is dependent on the timing of exposure.
    Cairney M; Campo MS
    Carcinogenesis; 1995 Aug; 16(8):1997-2001. PubMed ID: 7634432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between bovine papillomavirus type 4 and the flavonoid quercetin in cell transformation in vitro.
    Pennie WD; Campo MS
    Virology; 1992 Oct; 190(2):861-5. PubMed ID: 1325710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin, E7 and p53 in papillomavirus oncogenic cell transformation.
    Beniston RG; Morgan IM; O'Brien V; Campo MS
    Carcinogenesis; 2001 Jul; 22(7):1069-76. PubMed ID: 11408351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the transforming functions of bovine papillomavirus type 4.
    Pennie WD; Grindlay GJ; Cairney M; Campo MS
    Virology; 1993 Apr; 193(2):614-20. PubMed ID: 8384749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of exogenous p53 and E6 oncoproteins in in vitro transformation by bovine papillomavirus type 4 (BPV-4): significance of the absence of an E6 ORF in the BPV-4 genome.
    Scobie L; Jackson ME; Campo MS
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():3001-8. PubMed ID: 9367387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BPV-4 co-carcinogen quercetin induces cell cycle arrest and up-regulates transcription from the LCR of BPV-4.
    Connolly JA; Morgan IM; Jackson ME; Campo MS
    Oncogene; 1998 May; 16(21):2739-46. PubMed ID: 9652740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1.
    O'Brien V; Campo MS
    Oncogene; 1998 Jul; 17(3):293-301. PubMed ID: 9690511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of specific DNA sequences in C127 mouse cells transformed by bovine papillomavirus type 4.
    Smith KT; Campo MS
    Oncogene; 1989 Apr; 4(4):409-13. PubMed ID: 2541389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells.
    Tsirimonaki E; Ullah R; Marchetti B; Ashrafi GH; McGarry L; Ozanne B; Campo MS
    Virus Res; 2006 Feb; 115(2):158-68. PubMed ID: 16168512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell transformation induced by bovine papillomavirus DNA as an assay for tumor promoters and chemopreventive agents.
    Tsang SS; Stich HF; Fujiki H
    Cancer Detect Prev; 1991; 15(5):423-7. PubMed ID: 1661204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine papillomavirus type 1-transformed primary mouse fibroblasts show no correlation between tumorigenicity and viral gene expression, but c-myc gene expression is elevated in tumorigenic cell lines.
    Agrawal R; Pelkonen J; Mäntyjärvi RA
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1527-32. PubMed ID: 1318945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts.
    Jaggar RT; Pennie WD; Smith KT; Jackson ME; Campo MS
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():3041-6. PubMed ID: 2177095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins.
    Bohl J; Hull B; Vande Pol SB
    J Virol; 2001 Jan; 75(1):513-21. PubMed ID: 11119620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.
    Ashrafi GH; Tsirimonaki E; Marchetti B; O'Brien PM; Sibbet GJ; Andrew L; Campo MS
    Oncogene; 2002 Jan; 21(2):248-59. PubMed ID: 11803468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic and chromium enhance transformation of bovine papillomavirus DNA-transfected C3H/10T1/2 cells.
    Kowalski LA; Tsang SS; Davison AJ
    Cancer Lett; 1996 May; 103(1):65-9. PubMed ID: 8616810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.
    Vance KW; Campo MS; Morgan IM
    J Virol; 2001 Mar; 75(6):2829-38. PubMed ID: 11222708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.
    Mäntyjärvi R; Sarkkinen H; Parkkinen S; Laatikainen A; Ryhänen A; Syrjänen K
    Intervirology; 1988; 29(6):311-9. PubMed ID: 2852654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.
    Chen JJ; Hong Y; Androphy EJ
    Virology; 1997 Sep; 236(1):30-6. PubMed ID: 9299614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4.
    O'Brien V; Ashrafi GH; Grindlay GJ; Anderson R; Campo MS
    Virology; 1999 Mar; 255(2):385-94. PubMed ID: 10069964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique.
    McBride AA; Dlugosz A; Baker CC
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5534-9. PubMed ID: 10805809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.